GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Savara Inc (FRA:YB4P) » Definitions » Net Income From Continuing Operations

Savara (FRA:YB4P) Net Income From Continuing Operations : €-94.89 Mil (TTM As of Mar. 2025)


View and export this data going back to . Start your Free Trial

What is Savara Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Savara's net income from continuing operations for the three months ended in Mar. 2025 was €-24.64 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2025 was €-94.89 Mil.

Savara Net Income From Continuing Operations Historical Data

The historical data trend for Savara's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Savara Net Income From Continuing Operations Chart

Savara Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Income From Continuing Operations
Get a 7-Day Free Trial Premium Member Only Premium Member Only -40.78 -38.07 -36.01 -50.16 -91.57

Savara Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Net Income From Continuing Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -18.72 -20.66 -21.85 -27.74 -24.64

Savara Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €-94.89 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Savara Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Savara Inc (FRA:YB4P) » Definitions » Net Income From Continuing Operations
Comparable Companies
UPB KURA TYRA RGNX RLAY ZBIO BCAX ARVN AMLX ZVRA VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
SVRA:USA YB4P:Germany
Address
1717 Langhorne Newtown Road, Suite 300, Langhorne, PA, USA, 19047
Website
https://www.savarapharma.com
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.

Savara Headlines

No Headlines